Product Information
FT SINUS SEVERE 325-200-5 MG is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.1082 per EA under NDC 70677100501. Its NADAC has been published 147 times since Sep 6, 2023.
FT SINUS SEVERE 325-200-5 MG
ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDEStrength
325; 200; 5 mg/1; mg/1; mg/1
Manufacturer
Strategic Sourcing Services LLCNDC
70677100501
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
4/25/2023
Pharmacological Classes
Price Statistics
The NADAC for FT SINUS SEVERE 325-200-5 MG has been published 147 times since Sep 6, 2023, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1082 per EA |
|---|---|
| All-time high | $0.1200 (May 15, 2024) |
| All-time low | $0.1017 (Sep 20, 2023) |
| 52-week high | $0.1176 |
| 52-week low | $0.1082 |
| Median price | $0.1132 |
| Average price | $0.1122 |
| Largest weekly change | +11.9% (Apr 17, 2024) |
| Weeks tracked | 147 |
| Tracking since | Sep 6, 2023 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of FT SINUS SEVERE 325-200-5 MG?
The current National Average Drug Acquisition Cost (NADAC) for FT SINUS SEVERE 325-200-5 MG, manufactured by Strategic Sourcing Services LLC, is $0.1082 per EA (NDC 70677100501), effective Jun 24, 2026.
How has the price of FT SINUS SEVERE 325-200-5 MG changed over time?
Over the history we have for it, the NADAC for FT SINUS SEVERE 325-200-5 MG has held within roughly two percent of its current level. It has been tracked across 147 weekly CMS publications since Sep 6, 2023.
What are the highest and lowest recorded NADAC prices for FT SINUS SEVERE 325-200-5 MG?
Since Sep 6, 2023, the NADAC for FT SINUS SEVERE 325-200-5 MG has ranged from a low of $0.1017 (Sep 20, 2023) to a high of $0.1200 (May 15, 2024), with a median of $0.1132 per EA.
Are there cheaper alternatives to FT SINUS SEVERE 325-200-5 MG?
3 NADAC-published products share the same active ingredient, strength, and dosage form as FT SINUS SEVERE 325-200-5 MG, but none are currently priced below it.
Who manufactures FT SINUS SEVERE 325-200-5 MG?
FT SINUS SEVERE 325-200-5 MG (NDC 70677100501) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification